Cedar Breast Clinic, McGill University Health Center, Royal Victoria Hospital, 687 Pine Ave W, Montreal, QC, H3H 1A1, Canada.
AJR Am J Roentgenol. 2013 Jan;200(1):W71-4. doi: 10.2214/AJR.11.7461.
The purpose of this article is to evaluate the concordance between tumor grade found on ultrasound-guided core biopsies of invasive ductal carcinomas of the breast and subsequent excision specimens.
We retrospectively studied 300 consecutive invasive ductal carcinomas (274 women) that were biopsied under sonographic guidance, using 14-gauge core needles exclusively, and that were subsequently excised surgically. A minimum of four cores were taken per lesion. Core biopsy grades were compared with final surgical grades (reference standard). Tumor grade was assigned using the standard modified Scarff-Bloom-Richardson system. The agreement rate was expressed in percentages and in kappa statistics; the rates of overestimation and underestimation were also assessed. The correlation between tumor size (small, ≤ 0.5 cm; medium, 0.6-2.4 cm; and large, ≥ 2.5 cm) and agreement rate was also evaluated.
The overall agreement between core biopsy and surgical pathology grade was 69% (simple κ = 0.46; 95% CI, 0.36-0.54). Agreement by biopsy grade was 86% (55/64) for grade 3, 66% (118/180) for grade 2, and 55% (23/42) for grade 1. Core biopsy underestimated 24% (70/286) and overestimated 7% (20/286) of the lesions. When discordant, core biopsy differed from excision by no more than one grade. Large tumors were more likely to show underestimation rather than overestimation when discordant (rate of underestimation, 92% for large, 81% for medium, and 33% for small tumors; p < 0.0031).
Ultrasound-guided core biopsy accurately predicts high-grade breast tumors but is moderately accurate for lower-grade lesions. Large tumor size negatively impacts the accuracy of tumor grade found on biopsy and is associated with underestimation.
本文旨在评估超声引导下乳腺浸润性导管癌核心穿刺活检与后续切除标本肿瘤分级的一致性。
我们回顾性研究了 300 例连续浸润性导管癌(274 例女性),这些患者均在超声引导下进行 14 号针芯穿刺活检,随后进行手术切除。每例病变至少取 4 个核心。核心活检分级与最终外科分级(参考标准)进行比较。肿瘤分级采用改良的 Scarff-Bloom-Richardson 系统标准进行评估。一致性率以百分比和 Kappa 统计表示;还评估了高估和低估的发生率。评估肿瘤大小(小,≤0.5cm;中,0.6-2.4cm;大,≥2.5cm)与一致性率之间的相关性。
核心活检与外科病理分级的总体一致性为 69%(简单 Kappa=0.46;95%CI,0.36-0.54)。3 级肿瘤的一致性为 86%(55/64),2 级肿瘤为 66%(118/180),1 级肿瘤为 55%(23/42)。核心活检低估了 24%(70/286),高估了 7%(20/286)的病变。当存在差异时,核心活检与切除标本的差异不超过 1 个等级。不一致时,大肿瘤的低估率(92%)高于高估率(81%),而小肿瘤的低估率(33%)则低于中肿瘤(p<0.0031)。
超声引导下核心穿刺活检能准确预测高级别乳腺肿瘤,但对低级别病变的准确性中等。肿瘤体积较大时会降低活检肿瘤分级的准确性,并与低估相关。